Jane E Mounteney (Jane Mounteney, Jane Mouteney)

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 8

Top Topics

Alcohol Consumption

Transcription Factor

Clinical Practice

Top Venues

Addiction (Abingdon, England)

This page only lists publications with an associated author ORCID identifier.

Publications

Paul N Griffiths, Thomas Seyler, Joanna M De Morais, Jane E Mounteney, Roumen S Sedefov
Opioid problems are changing in Europe with worrying signals that synthetic opioids may play a more significant role in the future. Addiction (Abingdon, England) 119 (8) (2023)
Paul N Griffiths, Thomas Seyler, Joanna M De Morais, Jane E Mounteney, Roumen S Sedefov
Opioid problems are changing in Europe with worrying signals that synthetic opioids may play a more significant role in the future. Addiction (Abingdon, England) (2023)
Amanda Roxburgh, Bulent Sam, Pirkko Kriikku, Jane E Mounteney, Antonio Castanera, Mario Dias, Isabelle Giraudon
Trends in MDMA-related mortality across four countries. Addiction (Abingdon, England) 116 (11) (2021)
Brendan Hughes, Liesbeth Vandam, Jane E Mounteney, Paul N Griffiths
Regulatory approaches to cannabidiol in the European Union: are market developments sowing the seeds of confusion? Addiction (Abingdon, England) 117 (1) (2021)
Paul N Griffiths, Jane E Mounteney, Roumen Sedefov
The same fundamental drivers but differently expressed: what can we learn from comparing the recent experiences with synthetic opioids in the US and Europe? Addiction (Abingdon, England) 116 (6) (2021)
Marica Ferri, Jane E Mounteney, Paul Griffiths
Low-risk drinking guidelines: a pragmatic approach to health promotion? Addiction (Abingdon, England) 114 (4) (2019)
Jane E Mounteney, Paul Griffiths, Roumen Sedefov, Michael Evans-Brown
Fentanils: a serious threat to public health. Addiction (Abingdon, England) 114 (5) (2019)
Jane E Mounteney, Andrew Cunningham, Teodora Groshkova, Roumen Sedefov, Paul Griffiths
Looking to the future-more concern than optimism that cryptomarkets will reduce drug-related harms. Addiction (Abingdon, England) 113 (5) (2017)